Form 8-K Iterum Therapeutics plc For: Aug 14
Last iterum therapeutics plc earnings: 11/12 04:30 pm
Check Earnings Report
| Impact snapshot | Event time: | ITRM | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ITRM alerts
ITRM alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ITRM alerts
High impacting Iterum Therapeutics Plc news events
Weekly update
A roundup of the hottest topics
ITRM
News
- Iterum Therapeutics PLC (NASDAQ: ITRM) had its price target lowered by analysts at Royal Bank of Canada to $10.00. They now have an "outperform" rating on the stock.MarketBeat
- Iterum Therapeutics PLC (NASDAQ: ITRM) had its "market perform" rating re-affirmed by analysts at Svb Leerink Llc. They now have a $4.00 price target on the stock, down previously from $14.00.MarketBeat
- Iterum Therapeutics PLC (NASDAQ: ITRM) was downgraded by analysts at Leerink Swann from an "outperform" rating to a "market perform" rating.MarketBeat
- Iterum Therapeutics Announces Topline Results from Phase 3 Clinical Trial of Oral and IV Sulopenem for the Treatment of Complicated Intra-abdominal InfectionsGlobeNewswire
- Is Iterum Therapeutics plc (ITRM) Going To Burn These Hedge Funds ? [Yahoo! Finance News]Yahoo! Finance News
- More
ITRM
SEC Filings
- 11/12/19 - Form 10-Q
- 11/12/19 - Form 8-K
- ITRM's page on the SEC website
- More